Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
07/2003
07/24/2003WO2003059345A1 Pharmaceutical compositions comprising valsartan and nep inhibitors
07/24/2003WO2003059324A1 Method of producing hollow, microporous particles which are intended, in particular, to be inhaled
07/24/2003WO2003059294A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
07/24/2003WO2003059288A2 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
07/24/2003WO2003059270A2 Method for reducing morbidity and mortality in critically ill patients
07/24/2003WO2003059269A2 Acridone inhibitors of impdh enzyme
07/24/2003WO2003059252A2 Use of a novel cell surface protease from group b streptococcus
07/24/2003WO2003059245A2 Method of treating asthma
07/24/2003WO2003045333A3 Treatment of hyperproliferative diseases using active vitamin d analogues
07/24/2003WO2003045332A3 Methods and compositions for treating lesions of the respiratory epithelium
07/24/2003WO2003043572A3 Methods and compositions related to irm compounds and toll-like receptor pathways
07/24/2003WO2003032918A3 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors
07/24/2003WO2003028713A3 3,4-methylenedioxy-substituted chalcones as therapeutic agents
07/24/2003WO2002042272A3 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
07/24/2003US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening
07/24/2003US20030139585 Oligonucleotide derivatives which are at least partly double-stranded and which have a 2'5'-linked oligonucleotide residue on at least one 3' end; use in formulating pharmaceutical for tumor therapy, infectious diseases
07/24/2003US20030139462 Antiinflammatory agents; autoimmune disease; antiarthritic agents
07/24/2003US20030139446 Reacting with acid mixed with solvent; salt formation
07/24/2003US20030139437 Respiratory system disorders; dextromethorphan in anhydrous solvents
07/24/2003US20030139435 N-heterocyclic inhibitors of TNF-alpha expression
07/24/2003US20030139428 Purine derivatives for treatment of gastrointestinal disorders, immunological disorders, neurological disorders
07/24/2003US20030139419 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
07/24/2003US20030139417 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof
07/24/2003US20030139415 Novel heterocycles 3
07/24/2003US20030139413 Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical composition containing them
07/24/2003US20030139407 Efficient synthesis of 5-heteroatom-containing -pyrazoles
07/24/2003US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders
07/24/2003US20030139401 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
07/24/2003US20030139383 Respiratory system disorders
07/24/2003US20030139376 Lipoxin A4 analogs
07/24/2003US20030139364 Methods and products for enhancing immune responses using imidazoquinoline compounds
07/24/2003US20030139353 Using topoisomerase inhibitor; antiarthritic agents; respiratory system disorders; skin disorders
07/24/2003US20030138925 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
07/24/2003US20030138815 Cyclic adenosine monophosphate (cAMP); drug screening; bronchodilators; antiinflammatory agents; immunomodulators; antiallergens; bioassays
07/24/2003US20030138559 Process for manufacturing a metered dose inhaler
07/24/2003US20030138441 A polynucleotide sequence which encodes a Dermatophagoides dust mite protein, wherein the codon usage pattern of the polynucleotide sequence resembles that of highly expressed mammalian genes
07/24/2003US20030138440 Multimeric proteins and methods of making and using same
07/24/2003US20030138422 Antibodies against growth and differentiation factor-8 (GDF-8), also known as myostatin, including fragments; muscle and bone degenerative disorders; muscular dystropy/atrophy; antidiabetic agents; congestive obstructive pulmonary disease
07/24/2003CA2474239A1 Substituted pyridazinones as inhibitors of p38
07/24/2003CA2472746A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
07/24/2003CA2472619A1 Fused pyrimidine derivates as rho-kinase inhibitors
07/24/2003CA2472204A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
07/24/2003CA2472168A1 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
07/24/2003CA2471744A1 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation
07/24/2003CA2471480A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
07/24/2003CA2470649A1 Mmp inhibitors
07/24/2003CA2470421A1 Use of a novel cell surface protease from group b streptococcus
07/24/2003CA2468610A1 Method for reducing morbidity and mortality in critically ill patients
07/23/2003EP1329511A1 Polypeptide having phospholipase a2 actiivty
07/23/2003EP1329451A1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
07/23/2003EP1329222A1 Isoflavone compositions for use in medicine
07/23/2003EP1328646A2 Regulation of human adenylate cyclase, type iv
07/23/2003EP1328634A2 Genes expressed in the cell cycle
07/23/2003EP1328631A2 Her-2/neu fusion proteins
07/23/2003EP1328624A2 B7-like molecules and uses thereof
07/23/2003EP1328622A2 Protein c or activated protein c-like molecules
07/23/2003EP1328548A2 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
07/23/2003EP1328524A2 Novel anticholinergics, method for the production thereof and use thereof as medicaments
07/23/2003EP1328516A1 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
07/23/2003EP1328514A1 Amide derivatives as nmda receptor antagonists
07/23/2003EP1328319A1 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases
07/23/2003EP1328272A1 Nf-kappa-b inhibitors
07/23/2003EP1328267A2 Method of treating cancer using dithiocarbamate derivatives
07/23/2003EP1328260A2 Methods and products related to pulmonary delivery of polysaccharides
07/23/2003EP1328254A2 Lipid formulations for target delivery
07/23/2003EP1254134B1 1,3-dihydro-2h-indol-2-one derivatives,and their use as ligands for v1b or v1b and v1a arginine-vasopressin-receptors
07/23/2003EP1228073B1 Imidazole compounds used as phosphodiesterase vii inhibitors
07/23/2003EP1223972B1 Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses
07/23/2003EP1107741B1 Orally administered controlled drug delivery system providing temporal and spatial control
07/23/2003EP1086096B1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
07/23/2003EP1032575B1 2,3-diaryl-pyrazolo(1,5-b)pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
07/23/2003EP1025083B1 Process for stereoselective synthesis of prostacyclin derivatives
07/23/2003EP1017711B1 Monocyclic compounds with four bifunctional residues having nk-2 antagonist action
07/23/2003EP0975636B1 1h-pyrazolo[3,4-d]pyrimidine-4,6-diones as t-cell proliferation inhibitors
07/23/2003EP0714408B1 Tryptase inhibitor
07/23/2003CN1432020A 嘌呤衍生物 Purine derivatives
07/23/2003CN1432018A Crystalline and amorphous form of triazolo (4,5-d) pyrimidine compound
07/23/2003CN1432012A Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain
07/23/2003CN1432011A Benzoamide piperidine compounds as substance P antagonists
07/23/2003CN1432007A Inhibitors of alpha L beta 2 mediated cell adhesion
07/23/2003CN1431941A 挤压模 Extrusion die
07/23/2003CN1431904A Protease inhitors
07/23/2003CN1431897A Peptide deformylase inhibitors
07/23/2003CN1431000A Adhibition ointment for relieving cough
07/23/2003CN1430967A Naringin used in preparing medicine for curing acute and chronic bronchitis
07/23/2003CN1115341C Substituted N-methyl-N-(4-(1H-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases
07/23/2003CN1115334C Pyridine derivative and pharmaceutical contg. same
07/23/2003CN1115152C Method for treating bronchitis with uridine triphosphates and related compounds
07/22/2003US6596791 Polymer complexes of glucuronoglucanes
07/22/2003US6596751 α-substituted carboxylic acid derivatives
07/22/2003US6596746 Cyclic protein tyrosine kinase inhibitors
07/22/2003US6596745 Method for treating fibrotic diseases with azolium chroman compounds
07/22/2003US6596738 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I):
07/22/2003US6596730 Phenyl urea and phenyl thiourea derivatives
07/22/2003US6596718 7-Morpholin-4yl-benzothiazole amide derivatives
07/22/2003US6596711 GABA B receptor agonists for use in the treatment of CNS disorders, such as muscle relaxation in spinal spasticity, cardiovascular disorders, asthma, gut motility disorders such as irritable bowel syndrome and gastroesophogeal reflux
07/22/2003US6596701 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
07/22/2003US6596687 Cell adhesion inhibitors
07/22/2003CA2275602C Novel carboxy substituted cyclic carboxamide derivatives
07/17/2003WO2003057888A1 Cell-specific expression/replication vector
1 ... 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 ... 878